within subject standard deviation in fully replicate design if carry over effect is present [General Sta­tis­tics]

posted by dshah  – India/United Kingdom, 2023-06-14 12:37 (167 d 22:56 ago) – Posting: # 23591
Views: 712

Hello Ankit!

As per PSG, the recommendation is parallel study.


❝ So how to calculate Swr when unequal carryover effect is present in full replicate study design?

Moreover, the study population is patient and you can not stop the treatment. So why fully replicate CO study?


Complete thread:

UA Flag
 Admin contact
22,811 posts in 4,783 threads, 1,642 registered users;
11 visitors (0 registered, 11 guests [including 2 identified bots]).
Forum time: 10:34 CET (Europe/Vienna)

Every man gets a narrower and narrower field of knowledge
in which he must be an expert in order to compete with other people.
The specialist knows more and more about less and less
and finally knows everything about nothing.    Konrad Lorenz

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz